newsfilter
← Latest News
GlobeNewswire·

ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights

Completed enrollment of patients contributing to the Phase 3 PROACT 1 accelerated approval efficacy analysis, positioning the Company for anticipated pivotal eGFR slope topline results in Q2 2027On track for completion